These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6513680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Elimination of drugs in cholecystectomized patients. Studies with silymarin in patients with extrahepatic complications].
    Lorenz D, Mennicke WH.
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():103-106S. PubMed ID: 7321653
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients.
    Schandalik R, Gatti G, Perucca E.
    Arzneimittelforschung; 1992 Jul; 42(7):964-8. PubMed ID: 1329780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Elimination of silymarin by cholecystectomied patients. 2. Biliary elimination after multiple oral doses].
    Lorenz D, Mennicke WH, Behrendt W.
    Planta Med; 1982 Aug; 45(4):216-23. PubMed ID: 7134299
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of carsyl (silymarin) in experimental animals].
    Ognianova V, Drensk A, Mikhaĭlova D, Nachev I.
    Eksp Med Morfol; 1981 Aug; 20(4):214-20. PubMed ID: 7327148
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application.
    Wu JW, Lin LC, Hung SC, Chi CW, Tsai TH.
    J Pharm Biomed Anal; 2007 Nov 30; 45(4):635-41. PubMed ID: 17692492
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].
    Baier R, Puppel H, Zelder O, Zehner R.
    Arzneimittelforschung; 1981 Nov 30; 31(5):857-61. PubMed ID: 6456008
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide.
    D'Andrea V, Pérez LM, Sánchez Pozzi EJ.
    Life Sci; 2005 Jun 24; 77(6):683-92. PubMed ID: 15921999
    [Abstract] [Full Text] [Related]

  • 14. [Biliary excretion of apalcillin. Experimental study and evaluation in man].
    Brogard JM, Adloff M, Pinget M, Dorner M, Lautier F.
    Pathol Biol (Paris); 1985 Feb 24; 33(2):121-8. PubMed ID: 3889782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.
    Wu JW, Tsai TH.
    Drug Metab Dispos; 2007 Sep 24; 35(9):1603-10. PubMed ID: 17540707
    [Abstract] [Full Text] [Related]

  • 20. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R.
    Prostate; 2002 Nov 01; 53(3):211-7. PubMed ID: 12386921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.